Wellington Management Group’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-110,701
Closed -$586K 2083
2025
Q2
$586K Buy
110,701
+28,495
+35% +$207K ﹤0.01% 1797
2025
Q1
$669K Buy
+82,206
New +$768K ﹤0.01% 1785
2024
Q3
Sell
-73,207
Closed -$580K 2008
2024
Q2
$580K Buy
73,207
+7,794
+12% +$74.1K ﹤0.01% 1766
2024
Q1
$1.05M Buy
65,413
+37,532
+135% +$607K ﹤0.01% 1682
2023
Q4
$383K Buy
+27,881
New +$320K ﹤0.01% 1744

Other funds holding RCEL

Wellington Management Group's RCEL Position: Q3 2025 in Review

Wellington Management Group sold out of Avita Medical (RCEL) in Q3 2025, closing a stake of 110,701 shares — an estimated $586K sold.

Wellington Management Group first reported a position in RCEL in Q4 2023 and held it in 5 quarters. The position peaked at $1.05M in Q1 2024. 76 funds tracked by Wall St. Rank hold RCEL as of Q3 2025.

  • Wellington Management Group reported no remaining Avita Medical position as of Q3 2025 after selling out during the quarter.
  • Wellington Management Group sold 110,701 Avita Medical shares in Q3 2025, an estimated $586K.
  • Wellington Management Group first reported a position in Avita Medical in Q4 2023 and held it in 5 quarters.
  • Wellington Management Group's Avita Medical position peaked at $1.05M in Q1 2024.
  • 76 funds tracked by Wall St. Rank held Avita Medical as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.